Abstract:Inflammation is activated by diverse triggers that induce the expression of cytokines and adhesion molecules, which permit a succession of molecules and cells to deliver stimuli and functions that help the immune system clear the primary cause of tissue damage, whether this is an infection, a tumor, or a trauma. During inflammation, short-term changes in the expression and secretion of strong mediators of inflammation occur, while long-term changes occur to specific groups of cells. Long-term changes include cellular transdifferentiation for some types of cells that need to regenerate damaged tissue, as well as death for specific immune cells that can be detrimental to tissue integrity if they remain active beyond the boundaries of essential function. The transcriptional regulator NFκB enables some of the fundamental gene expression changes during inflammation, as well as during tissue development. During recurrence of malignant disease, cell stress-induced alterations enable the growth of cancer cell clones that are substantially resistant to therapeutic intervention and to the immune system. A number of those alterations occur due to significant defects in feedback signal cascades that control the activity of NFκB. Specifically, cell stress contributes to feedback defects as it overrides modules that otherwise control inflammation to protect host tissue. NFκB is involved in both the suppression and promotion of cancer, and the key distinctive feature that determines its net effect remains unclear. This paper aims to provide a clear answer to at least one aspect of this question, namely the mechanism that enables a divergent response of cancer cells to critical inflammatory stimuli and to cell stress in general.

Inflammation meets cancer, with NF-κB as the matchmaker

NF-κB, inflammation, immunity and cancer: coming of age

From Inflammation to Cancer: the Molecular Basis

Versatile function of NF-ĸB in inflammation and cancer

Inflammation and tissue homeostasis: the NF-κB system in physiology and malignant progression

NF‐κB signaling in inflammation and cancer

The complexity of NF-κB signaling in inflammation and cancer

NF-B signaling in inflammation and cancer

Tumor Necrosis Factor and Cancer, Buddies or Foes?

NF-κB Signaling Pathway in Tumor Microenvironment

Divergent Processing of Cell Stress Signals as the Basis of Cancer Progression: Licensing NFκB on Chromatin

Inflammation-induced Cancer: Crosstalk Between Tumours, Immune Cells and Microorganisms

Immunity, Inflammation, and Cancer

Chronic Inflammation and Cancer: Key Pathways and Targeted Therapies

Role of the NF&kappa;B-signaling Pathway in Cancer

Role of IKK-NFκB Signaling Pathway in Inflammation and Tumorigenesis

NF-κB signaling in inflammation

Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches

Nf-Kappa B Signaling in Inflammation

NF-κB、Tumorigenesis and Drug Development

Inflammation,Promoting Cancer or Protecting the Body Against Cancer?